Papers
3
Total Citations
46
H-Index
3
About
Howard E. Morgan is a radiation oncologist whose research centers on stereotactic partial breast irradiation (S-PBI) for early-stage breast cancer. His major contributions involve pioneering dose-escalation studies to optimize adjuvant radiotherapy after lumpectomy. In a multi-institutional Phase 1 trial, Morgan demonstrated the safety and feasibility of single-fraction S-PBI, achieving 23 citations for this foundational work. He further evaluated cosmetic outcomes in a 5-fraction regimen, showing that higher doses can maintain favorable breast appearance—a critical patient-centered endpoint. His most recent work explores pre-operative single-fraction ablative therapy, pushing the boundaries of non-invasive treatment. With over 46 citations across his key papers, Morgan’s research directly shapes clinical protocols for partial breast irradiation, offering women with early-stage breast cancer shorter, more targeted treatment options. His systematic approach to dose escalation and cosmetic assessment provides a roadmap for integrating S-PBI into standard care, making him a leading voice in breast cancer radiotherapy innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3